Alejandro Bernal, Director. Mr. Bernal has been a director since February 2023. Mr. Bernal has served as Chief Executive Officer of PetDx® – The Liquid Biopsy Company for Pets™, a company based in San Diego, CA, and focused on early detection of cancer using Next Generation Sequencing (NGS) since January 2023. Previously, between March 2018 and December 2022, Mr. Bernal was the President for Mars Veterinary Health International and Global Diagnostics, a global leader in pet food and veterinary health services. Prior to Mars, Mr. Bernal worked 17 years for Zoetis (formerly Pfizer Animal Health) and was a member of the Executive Team for 10 years. While at Zoetis, Mr. Bernal was responsible for commercial areas such as Canada and Latin America, and Europe, Middle East and Africa (EMEA). His last role at Zoetis was Executive Vice President and Group President of Strategy, Commercial and Business Development. During his time in Europe, Mr. Bernal was elected chairman for the 2011-13 and the 2013-2015 terms of the Council for the International Federation of Animal Health Europe (IFAH Europe -- today called Health for Animals Europe, the animal health pharmaceutical trade association for Europe Africa and Middle East). Mr. Bernal holds a Doctorate in veterinary medicine from Universidad de Caldas (Colombia), a Master’s Degree in Physiology from Texas A&M University (USA), and a Master of Business Administration from Universidad de los Andes (Colombia) and Manchester Business School (UK). Mr. Bernal is qualified to serve on our Board of Directors due to his extensive management and leadership experience in all facets of the animal health industry, including in corporate strategy and business development.